About this Journal Submit a Manuscript Table of Contents
ISRN Organic Chemistry
Volume 2012 (2012), Article ID 873035, 9 pages
http://dx.doi.org/10.5402/2012/873035
Research Article

Interaction of 5′-Guanosine Monophosphate with Organotin(IV) Moieties: Synthesis, Structural Characterization, and Anti-Inflammatory Activity

1Department of Chemistry, Indian Institute of Technology Roorkee, Uttrakhand, Roorkee 247667, India
2Department of Chemistry and Physics, University of the District of Columbia, Washington, DC 20008, USA

Received 16 July 2012; Accepted 6 September 2012

Academic Editors: N. Farfan, G. Giambastiani, and J. R. Hwu

Copyright © 2012 Mala Nath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. G. Ward and R. C. Taylor, “Anti-tumor activity of the main-group elements: aluminum, gallium, indium, thallium, germanium, lead, antimony and bismuth,” in Metal-Based Anti-Tumor Drugs, M. F. Gielen, Ed., pp. 1–54, Freund Publishing House, London, UK, 1988.
  2. B. Rosenberg, L. VanCamp, J. E. Trosko, and V. H. Mansour, “Platinum compounds: a new class of potent antitumour agents,” Nature, vol. 222, no. 5191, pp. 385–386, 1969. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Rosenb, “Cis-platin: its history and possible mechanisms of action,” in Cis-Platin-Current Status and New Developments, A. W. Prestayko, S. T. Crooke, and S. K. Carter, Eds., pp. 9–20, Academic Press, New York, NY, USA, 1980.
  4. P. M. May and R. A. Bulman, “The present status of chelating agents in medicine,” Progress in Medicinal Chemistry, vol. 20, pp. 225–336, 1983. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Köpf-Maier and H. Köpf, “Non-platinum-group metal antitumor agents: history, current status, and perspectives,” Chemical Reviews, vol. 87, no. 5, pp. 1137–1152, 1987. View at Scopus
  6. B. K. Keppler, C. Friesen, H. G. Moritz, H. Vongerichten, and E. Vogel, “Tumorinhibiting bis(β-diketonato) metal complexes. Budotitane, cis-diethoxybis(1- phenylbutane-1,3-dionato)titanium(IV); The first transition metal complex after platinum to qualify for clinical trials,” Structure and Bonding, vol. 78, pp. 97–127, 1991.
  7. S. Fruhauf and W. J. Zeller, “In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors,” Cancer Chemotherapy and Pharmacology, vol. 27, no. 4, pp. 301–307, 1991. View at Scopus
  8. G. Sava, S. Zorzet, and T. Giraldi, “Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms,” European Journal of Cancer and Clinical Oncology, vol. 20, no. 6, pp. 841–847, 1984. View at Scopus
  9. C. Pettinari and F. Marchetti, “Chemical and biotechnological developments in organotin cancer chemotherapy,” in Tin Chemistry, Fundamentals, Frontiers, and Applications, A. G. Davies, M. Gielen, K. H. Pannell, and E. R. T. Tiekink, Eds., pp. 454–468, John Wiley & Sons, New York, NY, USA, 2008.
  10. A. K. Saxena and F. Huber, “Organotin compounds and cancer chemotherapy,” Coordination Chemistry Reviews, vol. 95, no. 1, pp. 109–123, 1989. View at Scopus
  11. M. Gielen, P. Lelieveld, D. de Vos, and R. Willem, “In vitro antitumor activity of organotin compounds,” in Metal-Based Antitumor Drugs, M. Gielen, Ed., pp. 29–54, Freund Publishing House, London, UK, 1992.
  12. M. J. Clarke, F. Zhu, and D. R. Frasca, “Non-platinum chemotherapeutic metallopharmaceuticals,” Chemical Reviews, vol. 99, no. 9, pp. 2511–2533, 1999. View at Scopus
  13. M. Nath, S. Pokharia, and R. Yadav, “Organotin(IV) complexes of amino acids and peptides,” Coordination Chemistry Reviews, vol. 215, no. 1, pp. 99–149, 2001. View at Scopus
  14. M. Nath, S. Pokharia, G. Eng, X. Song, and A. Kumar, “Comparative study of structure-activity relationship of di- and tri- organotin(IV) derivatives of amino acid and peptides,” Journal of Organometallic Chemistry, vol. 669, no. 1-2, pp. 109–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nath, S. Pokharia, G. Eng, X. Song, and A. Kumar, “Diorganotin(IV) derivatives of dipeptides containing at least one essential amino acid residue: synthesis, characteristic spectral data, cardiovascular, and anti-inflammatory activities,” Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, vol. 34, no. 10, pp. 1689–1708, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nath, R. Jairath, G. Eng, X. Song, and A. Kumar, “Interaction of triorganotin(IV) cations with pyrimidine bases/nucleoside: synthesis, spectral characterization and biological studies of a novel triphenyltin(IV) derivative of thymidine,” Inorganic Chemistry Communications, vol. 7, no. 10, pp. 1161–1163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Nath, S. Pokharia, G. Eng et al., “New trimethyltin(IV) derivatives of dipeptides: synthesis, characteristic spectral studies and biological activity,” Applied Organometallic Chemistry, vol. 18, no. 9, pp. 460–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Nath, S. Pokharia, G. Eng, X. Song, and A. Kumar, “New triorganotin(IV) derivatives of dipeptides as anti-inflammatory- antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 40, no. 3, pp. 289–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Nath, S. Pokharia, G. Eng, X. Song, and A. Kumar, “New triorganotin (IV) derivatives of dipeptides as models for metal-protein interactions: synthesis, structural characterization and biological studies,” Spectrochimica Acta—Part A, vol. 63, no. 1, pp. 66–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Nath, H. Singh, P. Kumar, A. Kumar, X. Song, and G. Eng, “Organotin(IV) tryptophanylglycinates: potential non-steroidal anti inflammatory agents; crystal structure of dibutyltin(IV) tryptophanylglycinate,” Applied Organometallic Chemistry, vol. 23, no. 9, pp. 347–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nath, H. Singh, G. Eng, X. Song, and A. Kumar, “Syntheses, characterization and biological activity of diorganotin(IV) derivatives of 2-amino-6-hydroxypurine (guanine),” Inorganic Chemistry Communications, vol. 12, no. 10, pp. 1049–1052, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Nath, H. Singh, G. Eng, and X. Song, “Interaction of organotin(IV) moieties with nucleic acid constituent: synthesis, structural characterization and anti-inflammatory activity of tri-i-propyltin(IV) and diorganotin(IV) derivatives of guanosine,” Inorganic Chemistry Communications, vol. 14, no. 9, pp. 1381–1385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Roberts and J. M. Pascoe, “Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds,” Nature, vol. 235, no. 5336, pp. 282–284, 1972. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Sherman and S. J. Lippard, “Structural aspects of platinum anticancer drug interactions with DNA,” Chemical Reviews, vol. 87, no. 5, pp. 1153–1181, 1987. View at Scopus
  25. R. Barbieri, G. Alonzo, and R. H. Herber, “The configuration and lattice dynamics of complexes of dialkyltin(IV) with adenosine 5-monophosphate and phenyl phosphates,” Journal of the Chemical Society, Dalton Transactions, no. 4, pp. 789–794, 1987. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Li, P. Yang, H. Wang, and G. Maolin, “Diorganotin(IV) antitumor agent. (C2H5)2SnCl2 (phen)/nucleotides aqueous and solid-state coordination chemistry and its DNA binding studies,” Journal of Inorganic Biochemistry, vol. 64, no. 3, pp. 181–195, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Li, P. Yang, E. Hua, and C. Tian, “Diorganotin(IV) antitumour agents. Aqueous and solid-state coordination chemistry of nucleotides with R2SnCl2,” Journal of Coordination Chemistry, vol. 40, no. 3, pp. 227–236, 1996. View at Scopus
  28. Z. Yang, T. Bakas, A. Sanchez-Diaz, C. Charalampopoulos, J. Tsangaris, and N. Hadjiliadis, “Interaction of Et2SnCl2 with 5-IMP and 5-GMP,” Journal of Inorganic Biochemistry, vol. 72, no. 3-4, pp. 133–140, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Atkinson, M. D. Rodriguez, T. E. Shewmaker T., and J. A. Walmsley, “Synthesis and characterization of compounds of di- and tributyltin chloride with adenine and guanine mononucleotides,” Inorganica Chimica Acta, vol. 285, no. 1, pp. 60–69, 1999. View at Scopus
  30. H. Jankovics, L. Nagy, N. Buzás, L. Pellerito, and R. Barbieri, “Coordination properties of adenosine-5-monophosphate and related ligands towards Me2Sn(IV)2+ in aqueous solution,” Journal of Inorganic Biochemistry, vol. 92, no. 1, pp. 55–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Sekine, T. Kamimura, and T. Hata, “A convenient method for the synthesis of P1-(7-methylguanosine- 5) P2-(ribonucleoside-5) diphosphates,” Journal of the Chemical Society, Perkin Transactions 1, pp. 997–1000, 1985. View at Scopus
  32. M. Nath, S. Pokharia, X. Song et al., “New organotin(IV) derivatives of dipeptides as models for metal-protein interactions: in vitro anti-tumour activity,” Applied Organometallic Chemistry, vol. 17, no. 5, pp. 305–314, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Nath, R. Yadav, G. Eng, T. T. Nguyen, and A. Kumar, “Characteristic spectral studies, and antimicrobial and anti-inflammatory activities of diorganotin(IV) derivatives of dipeptides,” Journal of Organometallic Chemistry, vol. 577, no. 1, pp. 1–8, 1999. View at Scopus
  34. M. Math, R. Yadav, G. Eng, and P. Musingarimi, “Synthesis, spectral studies, in vitro antimicrobial and in vivo multi-infection antifungal activities in mice of new organotin(IV) derivatives of amino acids,” Journal of Chemical Research—Part S, no. 8, article 409, 1998. View at Publisher · View at Google Scholar · View at Scopus